CXCR4 overexpression was associated with both PFS and OS in seven subtypes of cancers (hematological malignancy, breast cancer, colorectal cancer, esophageal cancer, renal cancer, gynecologic cancer, and liver cancer). This evidence concerns the gene CXCR4 and renal carcinoma.